se of Goserelin for medical treatment of Uterine fibroids
Phase 4
- Conditions
- terine fibrois
- Registration Number
- RBR-3r88x9
- Lead Sponsor
- Financiamento próprio
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Woman; older than 18 year; diagnosis of uterine fibroids
Exclusion Criteria
Menopause; cancer; drug hypersensitivity
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of uterus evaluated by ultrasonography 3 months after treatment, 50% of reduction is estimated;Good acceptance of the treatment evaluated by a treatment satisfaction questionnaire, applied in only one situation
- Secondary Outcome Measures
Name Time Method Improvement of hemoglobin in laboratory exams ;Reduction of pain informed by the pacients, 3 months after treatment;Reduction of vaginal bleeding informed by the pacients, 3 months after treatment